NCT07040735

Brief Summary

Low-flow anesthesia (LFA) is a technique in which at least 50% of the exhaled air, after carbon dioxide absorption, is mixed with a certain amount of fresh gas and returned to the patient during the next inspiration. In 1974, R. Virtue defined minimal flow anesthesia (MFA) as 0.5 L/min. In 1984, Baker and Simionescu classified LFA as 0.5-1 L/min and MFA as 0.25-0.5 L/min. The aim of this study is to investigate whether there are hemodynamic differences between open-heart surgery cases performed with LFA at different fresh gas flow rates.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 27, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

June 6, 2025

Last Update Submit

June 30, 2025

Conditions

Keywords

Low-flow anesthesiaHemodynamicsOpen-heart surgery

Outcome Measures

Primary Outcomes (5)

  • physiological parameter ; heart rate

    Heart rate will be recorded every 10 minutes, expressed as beats per minute, starting before induction and including the sternotomy and pericardiotomy periods.

    Intraoperatively

  • physiological parameter; systolic/diastolic blood pressure

    Systolic and diastolic blood pressure will be recorded every 10 minutes in mmHg, starting before induction and including the sternotomy and pericardiotomy periods.

    Intraoperatively

  • physiological parameter; SpO2

    SpO2 will be recorded as a percentage every 10 minutes, starting before induction and including the sternotomy and pericardiotomy periods.

    Intraoperatively

  • Monitoring parameter; Bispectral Index (BIS)

    The BIS value will be recorded numerically every 10 minutes, starting from before induction and including the sternotomy and pericardiotomy periods.

    Intraoperatively

  • Monitoring parameter; Minimum alveolar concentration (MAC)

    The MAC value will be recorded numerically every 10 minutes, starting from before induction and including the sternotomy and pericardiotomy periods.

    Intraoperatively

Secondary Outcomes (3)

  • Preoperative data; ASA classification

    24 hours before surgery

  • Preoperative data

    24 hours before surgery

  • Preoperaitive data

    24 hours before surgery

Study Arms (4)

Group 1

Followed using Bispectral Index (BIS) with 4% Sevoflurane and fresh gas flow set at 0.5 L/min

Group 2

Followed using Minimum Alveolar Concentration (MAC) with 4% Sevoflurane and fresh gas flow set at 0.5 L/min

Group 3

Followed using BIS with 4% Sevoflurane and fresh gas flow set at 1 L/min

Group 4

Followed using MAC with 4% Sevoflurane and fresh gas flow set at 1 L/min

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

≥18 years and scheduled for open-heart surgery patients

You may qualify if:

  • ≥18 years and scheduled for open-heart surgery patients
  • ASA I-II-III-IV physical class

You may not qualify if:

  • Emergency cases
  • Patients under 18 years of age
  • Patients who have had open heart surgery before
  • Patients for whom the use of inhaled anesthetic agents is contraindicated
  • Patients who do not sign a voluntary consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Medicine

Ankara, Turkey (Türkiye)

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
asst. prof.

Study Record Dates

First Submitted

June 6, 2025

First Posted

June 27, 2025

Study Start

July 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

July 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations